Evidence map›Paper›PMID 38130931›Full record

Trial reportPeerJ2023

Psychometric validation of the Ostomy Skin Tool 2.0.

Gregor Jemec, Nana Overgaard Herschend, Helle Doré Hansen, Amy Findley, Abi Williams, Kate Sully, Tonny Karlsmark, Zenia Størling

Abstract readClinical TrialValidation Study
In one paragraph

Trial report in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gregor JemecDepartment of Dermatology, Roskilde Hospital, Roskilde, Denmark.
Nana Overgaard HerschendClinical Strategies, Coloplast A/S, Humlebæk, Denmark.
Helle Doré HansenClinical Strategies, Coloplast A/S, Humlebæk, Denmark.
Amy FindleyPatient-Centered Outcomes, Adelphi Values, Bollington, United Kingdom.
Abi WilliamsPatient-Centered Outcomes, Adelphi Values, Bollington, United Kingdom.
Kate SullyPatient-Centered Outcomes, Adelphi Values, Bollington, United Kingdom.
Tonny KarlsmarkCopenhagen Wound Healing Centre, Department of Dermatology, Bispebjerg Hospital, København, Denmark.
Zenia StørlingClinical Strategies, Coloplast A/S, Humlebæk, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Peristomal skin complications (PSCs) pose a major challenge for people living with an ostomy. To avoid severe PSCs, it is important that people with an ostomy check their peristomal skin condition on a regular basis and seek professional help when needed. Aim: To validate a new ostomy skin tool (OST 2.0) that will make regular assessment of the peristomal skin easier. Methods: Seventy subjects participating in a clinical trial were eligible for the analysis and data used for the validation. Item-level correlation with anchors, inter-item correlations, convergent validity of domains, test-retest reliability, anchor- and distribution-based methods for assessment of meaningful change were all part of the psychometric validation of the tool. Results: A final tool was established including six patient reported outcome items and automatic assessment of the discolored peristomal area. Follow-up with cognitive debriefing interviews assured that the concepts were considered relevant for people with an ostomy. Conclusion: The OST 2.0 demonstrated evidence supporting its reliability and validity as an outcome measure to capture both visible and non-visible peristomal skin complications.

Indexed as

OstomySkin DiseasesHumansPsychometricsReproducibility of ResultsSkinOstomyOstomy skin toolPeristomal skinPsychometric validation

Identifiers

PMID38130931
PMCPMC10734405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.